Overview

ASTERIX: Low Dose ASA and Nexium

Status:
Completed

Trial end date:
2005-09-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the effect of esomeprazole 20 mg od versus placebo for the prevention of gastric and/or duodenal ulcers in patients taking low-dose ASA.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Esomeprazole